Strides receives FDA warning letter and defers 10 ANDAs 02-Jul-2019 By Ben Hargreaves Strides’ Puducherry, India, facility has received a warning letter from the US FDA, which the company announced will lead to deferrals for 10 pending ANDA approvals.
UPDATED Strides hamstrung by US FDA Form 483 20-Sep-2018 By Ben Hargreaves Strides announced that a US FDA inspection of its Bangalore facility has resulted in a Form 483, noting three observations.